119 related articles for article (PubMed ID: 28962916)
21. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
22. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.
Ruiz XD; Mlakar LR; Yamaguchi Y; Su Y; Larregina AT; Pilewski JM; Feghali-Bostwick CA
PLoS One; 2012; 7(8):e43049. PubMed ID: 22900087
[TBL] [Abstract][Full Text] [Related]
23. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.
Montagnani Marelli M; Moretti RM; Procacci P; Motta M; Limonta P
Int J Oncol; 2006 Mar; 28(3):723-30. PubMed ID: 16465378
[TBL] [Abstract][Full Text] [Related]
25. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
26. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
27. Increased phosphorylation of ezrin is associated with the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Xiao Y; Sun M; Zhan Z; Ye Y; Huang M; Zou Y; Liang L; Yang X; Xu H
Rheumatology (Oxford); 2014 Jul; 53(7):1291-300. PubMed ID: 24599913
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
[TBL] [Abstract][Full Text] [Related]
29. Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology.
Chen CY; Lin CW; Chang CY; Jiang ST; Hsueh YP
J Cell Biol; 2011 May; 193(4):769-84. PubMed ID: 21555464
[TBL] [Abstract][Full Text] [Related]
30. Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration.
Zhang X; Lin M; van Golen KL; Yoshioka K; Itoh K; Yee D
Breast Cancer Res Treat; 2005 Sep; 93(2):159-68. PubMed ID: 16187236
[TBL] [Abstract][Full Text] [Related]
31. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
[TBL] [Abstract][Full Text] [Related]
32. N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA
Corti F; Wang Y; Rhodes JM; Atri D; Archer-Hartmann S; Zhang J; Zhuang ZW; Chen D; Wang T; Wang Z; Azadi P; Simons M
Nat Commun; 2019 Apr; 10(1):1562. PubMed ID: 30952866
[TBL] [Abstract][Full Text] [Related]
33. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells.
Berdiaki A; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
Biochim Biophys Acta; 2009 Oct; 1790(10):1258-65. PubMed ID: 19577615
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
35. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
Tiffin N; Adi S; Stokoe D; Wu NY; Rosenthal SM
Endocrinology; 2004 Nov; 145(11):4991-6. PubMed ID: 15489316
[TBL] [Abstract][Full Text] [Related]
36. Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
Yamada K; Oikawa T; Kizawa R; Motohashi S; Yoshida S; Kumamoto T; Saeki C; Nakagawa C; Shimoyama Y; Aoki K; Tachibana T; Saruta M; Ono M; Yoshida K
Cancer Res; 2021 Jan; 81(2):414-425. PubMed ID: 33318039
[TBL] [Abstract][Full Text] [Related]
37. Novel roles of local insulin-like growth factor-1 activation in gastric ulcer healing: promotes actin polymerization, cell proliferation, re-epithelialization, and induces cyclooxygenase-2 in a phosphatidylinositol 3-kinase-dependent manner.
Nguyen T; Chai J; Li A; Akahoshi T; Tanigawa T; Tarnawski AS
Am J Pathol; 2007 Apr; 170(4):1219-28. PubMed ID: 17392162
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
39. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
40. IGF-IR/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children.
Iñiguez G; Ormazabal P; López T; Maldonado D; Avila A; Román R; Cassorla F
Growth Horm IGF Res; 2009 Jun; 19(3):256-61. PubMed ID: 19217812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
